274 related articles for article (PubMed ID: 33086751)
1. The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer's Disease.
Bukke VN; Villani R; Archana M; Wawrzyniak A; Balawender K; Orkisz S; Ferraro L; Serviddio G; Cassano T
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33086751
[TBL] [Abstract][Full Text] [Related]
2. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAcylation and neuronal energy status: Implications for Alzheimer's disease.
Pinho TS; Verde DM; Correia SC; Cardoso SM; Moreira PI
Ageing Res Rev; 2018 Sep; 46():32-41. PubMed ID: 29787816
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
5. Distinct relationships of amyloid-beta and tau deposition to cerebral glucose metabolic networks in Alzheimer's disease.
Sun X; Nie B; Zhao S; Ai L; Chen Q; Zhang T; Pan T; Wang L; Yin X; Zhang W; Shan B; Liu H; Liang S; Wang G
Neurosci Lett; 2020 Jan; 717():134699. PubMed ID: 31874218
[TBL] [Abstract][Full Text] [Related]
6. N-glycan and Alzheimer's disease.
Kizuka Y; Kitazume S; Taniguchi N
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2447-2454. PubMed ID: 28465241
[TBL] [Abstract][Full Text] [Related]
7. The antimicrobial protection hypothesis of Alzheimer's disease.
Moir RD; Lathe R; Tanzi RE
Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
[TBL] [Abstract][Full Text] [Related]
8. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
[TBL] [Abstract][Full Text] [Related]
9. Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture.
Liu W; Zhuo P; Li L; Jin H; Lin B; Zhang Y; Liang S; Wu J; Huang J; Wang Z; Lin R; Chen L; Tao J
Free Radic Biol Med; 2017 Nov; 112():174-190. PubMed ID: 28756309
[TBL] [Abstract][Full Text] [Related]
10. Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.
Pascoal TA; Mathotaarachchi S; Shin M; Park AY; Mohades S; Benedet AL; Kang MS; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P;
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1021-1030. PubMed ID: 29396637
[TBL] [Abstract][Full Text] [Related]
11. Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies.
Mosconi L
Clin Transl Imaging; 2013 Aug; 1(4):. PubMed ID: 24409422
[TBL] [Abstract][Full Text] [Related]
12. Regulation of AβPP Glycosylation Modification and Roles of Glycosylation on AβPP Cleavage in Alzheimer's Disease.
Tao PF; Huang HC
ACS Chem Neurosci; 2019 May; 10(5):2115-2124. PubMed ID: 30802027
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
[TBL] [Abstract][Full Text] [Related]
14. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
Volloch V; Olsen BR; Rits S
Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
[TBL] [Abstract][Full Text] [Related]
15. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
16. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
[TBL] [Abstract][Full Text] [Related]
17. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
[TBL] [Abstract][Full Text] [Related]
18. Calcium signaling in Alzheimer's disease & therapies.
Tong BC; Wu AJ; Li M; Cheung KH
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1745-1760. PubMed ID: 30059692
[TBL] [Abstract][Full Text] [Related]
19. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.
Luo J; Lee SH; VandeVrede L; Qin Z; Ben Aissa M; Larson J; Teich AF; Arancio O; D'Souza Y; Elharram A; Koster K; Tai LM; LaDu MJ; Bennett BM; Thatcher GR
Mol Neurodegener; 2016 Apr; 11():35. PubMed ID: 27129593
[TBL] [Abstract][Full Text] [Related]
20. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
Duarte AI; Santos MS; Oliveira CR; Moreira PI
Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
